Southern Pointe Living Center | |
101 Sherrard Drive, Colbert, Oklahoma 74733 | |
(580) 296-4500 | |
Name | Southern Pointe Living Center |
---|---|
Location | 101 Sherrard Drive, Colbert, Oklahoma |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 95 |
Occupancy Rate | 40.42% |
Medicare ID (CCN) | 375469 |
Legal Business Name | Legal Business Name Not Available |
Ownership Type | For Profit - Corporation |
NPI Number | 1427045210 |
Organization Name | COLBERT NURSING HOME INC. |
Doing Business As | SOUTHERN POINTE LIVING CENTER |
Address | 101 Sherrard St, Colbert, OK 74733 |
Phone Number | 580-296-4500 |
News Archive
In this TIME "Ideas" opinion piece, David Bowen, CEO of Malaria No More, writes that with the right resources and political will, an end to malaria is possible.
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
Unison Health Plan of Pennsylvania, based in Monroeville, has joined its Philadelphia-based sister company, AmeriChoice of Pennsylvania, under the name UnitedHealthcare Community Plan. The combined plans serve more than 280,000 health plan members in Pennsylvania.
Researchers at Binghamton University, State University of New York have uncovered the unique way in which a type of Gram-negative bacterium delivers the toxins that make us sick. Understanding this mechanism may help design better ways to block and eventually control those toxins.
› Verified 8 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
In this TIME "Ideas" opinion piece, David Bowen, CEO of Malaria No More, writes that with the right resources and political will, an end to malaria is possible.
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
Unison Health Plan of Pennsylvania, based in Monroeville, has joined its Philadelphia-based sister company, AmeriChoice of Pennsylvania, under the name UnitedHealthcare Community Plan. The combined plans serve more than 280,000 health plan members in Pennsylvania.
Researchers at Binghamton University, State University of New York have uncovered the unique way in which a type of Gram-negative bacterium delivers the toxins that make us sick. Understanding this mechanism may help design better ways to block and eventually control those toxins.
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 11.71 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8.54 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 41.67 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 13.57 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 6.36 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 10.13 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.96 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 1.01 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.48 | 95.98 |